Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma, PDAC Intervention: Sponsor: Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Pancreas | Pancreatic Cancer | Research | Study